IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas

BACKGROUND: Epigenetic, genetic, and molecular studies have identified several diagnostic and prognostic markers in diffuse gliomas. Their importance for evaluating WHO grade II gliomas has yet to be specifically delineated. METHODS: We analyzed markers, including IDH mutation(IDHmut), 1p19q codelet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Leeper, Heather E., Caron, Alissa A., Decker, Paul A., Jenkins, Robert B., Lachance, Daniel H., Giannini, Caterina
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745799/
https://ncbi.nlm.nih.gov/pubmed/26210286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados